Physician profile
Leonardo Taarea
NPI 1912386848
$8,379.38
in general payments reported to CMS, 2019-2025
17 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,202 · 2020: $220 · 2021: $287 · 2022: $234 · 2023: $714 · 2024: $510 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,413 · Education: $23.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.67 |
| Education | $23.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,927.78 | 2019 | |
| Amgen INC. | $724.53 | 2020-2025 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $431.80 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $419.05 | 2020-2025 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $175.58 | 2019-2025 | Durolane, Xcell, Durolane |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $118.98 | 2023 | Seglentis |
| Depuy Synthes Sales INC. | $60.93 | 2021-2024 | Orthovisc, Monovisc |
| Exact Sciences Corporation | $59.48 | 2023-2024 | Cologuard Collection Kit |
| Radius Health, INC. | $56.17 | 2021 | |
| Boston Scientific Corporation | $54.33 | 2023 | Watchman Flx |
| Endo Pharmaceuticals INC. | $48.85 | 2020-2024 | Xiaflex |
| Lilly USA, LLC | $46.56 | 2023-2025 | Mounjaro, Zepbound |
| Ucb, INC. | $45.39 | 2022 | |
| Djo, LLC | $38.89 | 2023 | Donjoy, Aircast |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $23.53 | 2025 | |
| Biogen, INC. | $22.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Taarea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.